Yayınlar & Eserler

ATLAS Yayın Analitiği
Makaleler 16
Tümü (16)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (15)
ESCI (1)
Scopus (15)
TRDizin (1)

1. Clinicopathologic and molecular characteristics of colorectal cancer patients with brain metastases: a multicenter cohort study

Kemik F., Köylü B., Kıkılı C. İ., Demir N., Hamdard J., Güren A. K., et al.
Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. Effect of Maintenance Anti-EGFR Therapy on Survival in RAS Wild-Type Metastatic Colorectal Cancer: Real-World Data

Çokgezer S., ARTAN S., Topuz S., şenkal m., Azizy A., Sakar B., et al.
Cerrahpaşa Medical Journal , sa.1, ss.1-12, 2026 (TRDizin) Creative Commons License

3. Association of Maintenance Therapy Strategies with Survival Following First-Line Bevacizumab-Based Combination Chemotherapy in Metastatic Colorectal Cancer: A Single-Center Retrospective Observational Study

Cokgezer S., Sakar B., Karabulut S.
JOURNAL OF CLINICAL MEDICINE , cilt.15, sa.16, 2026 (SCI-Expanded, Scopus)

4. Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes

Yıldız A., AHMED M. A., Eren N. N., AZİZY A., ARTAN S., ÇOKGEZER S., et al.
Nutrients , cilt.18, sa.7, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Prognostic Role of Endocan and Platelet-Derived Growth Factor Isoforms in Metastatic Colorectal Cancer

Yildiz A., Ahmed M. A., Azizy A., Çokgezer S., Ulufer B., Soydinc H., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.27, sa.6, 2026 (SCI-Expanded, Scopus)

6. Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Dogan I., Tastekin D., Karabulut S., Sakar B.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded, Scopus)

7. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy

Aykan N. F., Yildiz I., Sen F., Kilic L., Keskin S., Ciftci R., et al.
MEDICAL ONCOLOGY , cilt.30, sa.3, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Saglam S., Aykan N. F., ŞAKAR B., GÜLLÜOĞLU M., Balik E., Karanlik H.
JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.2, sa.1, ss.19-26, 2011 (SCI-Expanded, ESCI, Scopus) Sürdürülebilir Kalkınma

9. Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: Single center experience from Turkey

Ustuner Z., Basaran M., Dizdar Y., Agaoglu F. Y., Bilgic B., Sakar B., et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.213, sa.3, ss.221-229, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas

Basaran M., Bavbek E. S., Saglam S., Eralp L., Sakar B., Atalar A. C., et al.
ONCOLOGY , cilt.72, ss.255-260, 2007 (SCI-Expanded, Scopus)

11. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

TAS F., USTUNER Z., CAN G., ERALP Y., CAMLICA H., BASARAN M., et al.
Acta oncologica (Stockholm, Sweden) , cilt.44, sa.2, ss.161-7, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Ewing's sarcoma of the axial system in patients older than 15 years: Dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment

Argon A., Basaran M., Yaman F., Dizdar Y., Sakar B., Camlica H., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.34, sa.11, ss.667-672, 2004 (SCI-Expanded, Scopus)

13. Clinicopathologic factors influencing survival of patients with bile duct and gallbladder carcinoma

Sakar B., Basaran M., Gumus M., Yazar A., Argon A., Aykan N. F.
ANNALS OF ONCOLOGY , cilt.15, ss.243-244, 2004 (SCI-Expanded, Scopus)

14. Colorectal cancer in young patients: Characteristics and outcome

Alici S., Aykan N., ŞAKAR B., Bulutlar G., Kaytan E., Topuz E.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.199, sa.2, ss.85-93, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer

Başaran M., Bavbek S., Güllü İ., Demirelli F. H., Şakar B., Tenekeci N., et al.
JOURNAL OF CHEMOTHERAPY , cilt.14, ss.207-213, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Hypertrophic osteoarthropathy associated with docetaxel treatment.

Tas F., Aydiner A., Tenekeci N., Karadeniz A. N., Sakar B., Topuz E.
Clinical oncology (Royal College of Radiologists (Great Britain)) , cilt.13, sa.2, ss.145-6, 2001 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Do serum nectin-2 levels have a prognostic effect in patients with colorectal cancer?

Basaran M., KARABULUT S., KARABULUT M., GUNALDI M., ALIS H., Erturk K., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Prognostic roles of serum NEDD9 levels in patients with gastric cancer.

Karabulut S., Karabulut M., Alis H., Bozbey H. U., Sakar B., Vatansever S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)

Keskin S., Sen F., AYDOGAN F., Ekenel M., Kilic L., SAGLAM S., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Opere lokal ileri mide kanserli hastalarda adjuvan kemoterapi ile kemoradyoterapinin etkinliğinin karşılaştırılması

ORDU C., KILIC L., EKENEL M., ŞAKAR B., AYKAN F.
III. Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 24 - 28 Mart 2010, ss.121, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

5. Chemoradiotherapy in the adjuvant treatment of gastric cancer

Saglam E. K., Ozturk B., Baskaya S., Saglam S., Sakar B., Yamaner S., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.315-316, (Özet Bildiri) Sürdürülebilir Kalkınma
Metrikler

Yayın

21

Yayın (WoS)

19

Yayın (Scopus)

15

Atıf (WoS)

169

H-İndeks (WoS)

7

Atıf (Scopus)

170

H-İndeks (Scopus)

6

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları
SDG 2: AMAÇ 2: AÇLIĞA SON
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 5: AMAÇ 5: CİNSİYET EŞİTLİĞİ
SDG 16: AMAÇ 16: BARIŞ VE ADALET